Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Mesenchymal Stem Cell Market Report. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Mesenchymal Stem Cell Trends and Forecast
The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets. The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Mesenchymal Stem Cell by Segment
The study includes a forecast for the global mesenchymal stem cell by workflow, type, application, and region.

Mesenchymal Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
• Cell Sourcing & Isolation
• Culture & Cryopreservation
• Differentiation
• Characterization







Mesenchymal Stem Cell Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Autologous
• Allogeneic









Mesenchymal Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Disease Modelling
• Drug Development & Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies
• Others

















Mesenchymal Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Mesenchymal Stem Cell Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mesenchymal stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mesenchymal stem cell companies profiled in this report include-
• Thermo Fisher Scientific
• Cell Applications
• Axol Biosciences
• Cytori Therapeutics
• STEMCELL Technologies
• Cyagen Biosciences
• Celprogen
• Brainstorm Cell
• Stemedica Cell Technologies
• Merck


Mesenchymal Stem Cell Market Insights
Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Features of the Global Mesenchymal Stem Cell Market

Market Size Estimates: Mesenchymal stem cell market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Mesenchymal stem cell market size by workflow, type, application, and region in terms of value ($B).
Regional Analysis: Mesenchymal stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different workflow, type, application, and regions for the mesenchymal stem cell market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mesenchymal stem cell market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the mesenchymal stem cell market size?
Answer: The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030.

Q.2 What is the growth forecast for mesenchymal stem cell market?
Answer: The global mesenchymal stem cell market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mesenchymal stem cell market?
Answer: The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

Q4. What are the major segments for mesenchymal stem cell market?
Answer: The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets.

Q5. Who are the key mesenchymal stem cell market companies?
Answer: Some of the key mesenchymal stem cell companies are as follows:
• Thermo Fisher Scientific
• Cell Applications
• Axol Biosciences
• Cytori Therapeutics
• STEMCELL Technologies
• Cyagen Biosciences
• Celprogen
• Brainstorm Cell
• Stemedica Cell Technologies
• Merck



Q6. Which mesenchymal stem cell market segment will be the largest in future?
Answer: Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

Q7. In mesenchymal stem cell market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the mesenchymal stem cell market by workflow (cell sourcing & isolation, culture & cryopreservation, differentiation, and characterization), type (autologous and allogeneic), application (disease modelling, drug development & discovery, stem cell banking, tissue engineering, toxicology studies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related to Mesenchymal Stem Cells Market, Mesenchymal Stem Cells Market Size, Mesenchymal Stem Cells Market Growth, Mesenchymal Stem Cells Market Analysis, Mesenchymal Stem Cells Market Report, Mesenchymal Stem Cells Market Share, Mesenchymal Stem Cells Market Trends, Mesenchymal Stem Cells Market Forecast, Mesenchymal Stem Cells Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents

1. Executive Summary

2. Global Mesenchymal Stem Cell Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges 

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Mesenchymal Stem Cell Market Trends (2018-2023) and Forecast (2024-2030)

3.3: Global Mesenchymal Stem Cell Market by Workflow
3.3.1: Cell Sourcing & Isolation
3.3.2: Culture & Cryopreservation
3.3.3: Differentiation
3.3.4: Characterization






3.4: Global Mesenchymal Stem Cell Market by Type
3.4.1: Autologous
3.4.2: Allogeneic








3.5: Global Mesenchymal Stem Cell Market by Application
3.5.1: Disease Modelling
3.5.2: Drug Development & Discovery
3.5.3: Stem Cell Banking
3.5.4: Tissue Engineering
3.5.5: Toxicology Studies
3.5.6: Others














4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Mesenchymal Stem Cell Market by Region
4.2: North American Mesenchymal Stem Cell Market
4.2.1: North American Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
4.2.2: North American Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others


4.3: European Mesenchymal Stem Cell Market

4.3.1: European Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
4.3.2: European Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others


4.4: APAC Mesenchymal Stem Cell Market

4.4.1: APAC Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
4.4.2: APAC Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others


4.5: ROW Mesenchymal Stem Cell Market

4.5.1: ROW Mesenchymal Stem Cell Market by Type: Autologous and Allogeneic
4.5.2: ROW Mesenchymal Stem Cell Market by Application: Disease Modelling, Drug Development & Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, and Others


5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Workflow
6.1.2: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Type
6.1.3: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Application

6.1.4: Growth Opportunities for the Global Mesenchymal Stem Cell Market by Region

6.2: Emerging Trends in the Global Mesenchymal Stem Cell Market

6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Mesenchymal Stem Cell Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Mesenchymal Stem Cell Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Thermo Fisher Scientific
7.2: Cell Applications
7.3: Axol Biosciences
7.4: Cytori Therapeutics
7.5: STEMCELL Technologies
7.6: Cyagen Biosciences
7.7: Celprogen
7.8: BrainStorm Cell
7.9: Stemedica Cell Technologies
7.10: Merck
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030 Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.

Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.

Please sign in below to get report brochure - Mesenchymal Stem Cell Market Report.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )